Latest Partnerships News

Page 547 of 562
Galan Lithium Limited has announced a substantial 150% increase in its Candelas Mineral Resource to 1.6 Mt LCE, lifting its total Hombre Muerto West resource to 9.5 Mt LCE and securing a spot among the world’s top 10 lithium projects.
Maxwell Dee
Maxwell Dee
29 Jan 2025
CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.
Ada Torres
Ada Torres
29 Jan 2025
Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.
Victor Sage
Victor Sage
29 Jan 2025
CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.
Ada Torres
Ada Torres
29 Jan 2025
Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.
Ada Torres
Ada Torres
29 Jan 2025
Agrimin Limited has achieved a major milestone with Western Australian state environmental approval for its Mackay Potash Project, alongside government-backed financial support and strategic progress toward project execution.
Victor Sage
Victor Sage
29 Jan 2025
Microba Life Sciences reported a robust Q2 FY25 with revenue more than doubling year-on-year, driven by strong sales of its MetaXplore microbiome test in Australia and promising early adoption in the UK.
Ada Torres
Ada Torres
29 Jan 2025
Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.
Ada Torres
Ada Torres
29 Jan 2025
Syntara Limited has reported encouraging interim Phase 2 trial results for its lead drug candidate SNT-5505 in myelofibrosis, alongside a successful A$15 million capital raise to advance multiple clinical programs.
Victor Sage
Victor Sage
29 Jan 2025
Vinyl Group Ltd delivered a standout Q2 FY25 with a 172% jump in cash receipts and strategic acquisitions poised to boost earnings. The company’s international expansion and debt reduction efforts signal a transformative phase ahead.
Elise Vega
Elise Vega
29 Jan 2025
Lightning Minerals reports a breakthrough spodumene discovery grading up to 4.04% Li2O at its Esperança project in Brazil, alongside multiple lithium drill targets across its Brazilian portfolio, setting the stage for a major drilling campaign in early 2025.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Aurelia Metals delivered a robust December quarter, marked by strong cash flow, increased metal output, and the successful processing of its first ore from the Federation mine, underpinning its FY25 guidance.
Maxwell Dee
Maxwell Dee
29 Jan 2025